Skip to content

Evaluation of reactive hyperemia and ischemia-reperfusion using the EndoPAT

Evaluation of reactive hyperemia and ischemia-reperfusion using the EndoPAT - Evaluation of endothelial function

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33369
Enrollment
60
Registered
2009-06-15
Start date
2009-03-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endothelial function

Interventions

None listed

Sponsors

Centre for Human Drug Research
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Be at least 18 years of age; Able to keep to the diet and other restrictions and instructions as listed in the protocol. Able and willing to sign the Informed consent form.

Exclusion criteria

Exclusion criteria: In general: any clinically significant disorder (current or past medical history or physical examination) that in the opinion of the investigator precludes study participation.

Design outcomes

Primary

MeasureTime frame
Heart rate variability, the augmentation index and hyperemia index.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)